Italy· 030705014

EPSOCLAR

A heparin product containing eparina sodica, registered in Italy by PFIZER ITALIA S.R.L., on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC B01AB01

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedEPSOCLARATCB01AB01REGISTER NO.030705014PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Heparin is registered in 12 of 19 countries.

Countries holding a registration under ATC B01AB01 (heparin), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 8 of them publish a price we can compare per daily dose

Heparin · ATC B01AB01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

AIFA (Italy)
Active substance
Eparina sodica
Manufacturer
PFIZER ITALIA S.R.L.
Country
Italy (IT)
ATC code
B01AB01
ATC class
Heparin
Defined daily dose
10 TSD, E
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    030705014
    "5000 UI/1 ML SOLUZIONE INIETTABILE PER USO SOTTOCUTANEO E ENDOVENOSO" 10 FIALE
    EUR 9.65

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

714 interactions on record for heparin.

Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Heparin · interactions on record

714 records

  • 63 severe
  • 133 moderate
  • 18 minor
  • 500 info

Most severe, free to view

  • InotersenN07XX15severe
  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Heparin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All heparin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Hungary · Heparibene Na
  • Norway · Heparin Leo Pharma
  • Romania · Heparina Galenica, Heparina Galenika

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/14819e68-bb11-464e-ae92-769762469644
GET /v1/drugs/14819e68-bb11-464e-ae92-769762469644?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"5000 UI/1 ML SOLUZIONE INIETTABILE PER USO SOTTOCUTANEO E ENDOVENOSO\" 10 FIALE",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Eparina sodica",
  "reference_pack": "10 UNITA' 5000 UI - USO PARENTERALE",
  "public_price_eur": 9.65,
  "ssn_reference_price_eur": 16.08
}

See everything about heparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.